Year 2023 in Review

The year 2023 has been full of activities and actions, that we have either conducted on our own or in partnership with national and European patient organisations (RaDiOrg, VPP, LUSS and EURORDIS), within VASCERN (the European Reference Network for Rare Vascular Diseases) and in particular within the VASCA-WG (Vascular Anomalies Working Group).

Through all these actions, we aim to drive faster and proper diagnosis of vascular anomalies, help and support people affected by these rare diseases, improve their life and possibilities of treatments, and make these diseases more visible at national and European level.

Key highlights of 2023

January–February: VASCAPA attended the VASCERN ePAG conference in Ghent, participated in the VAC2023 congress in Brussels, and engaged in Rare Disease Day campaigns. On February 16, we attended the Prix Generet ceremony recognising Prof. Vikkula’s research.

April–May: VASCAPA attended the ISSVA international meeting and participated in the first VASCERN ePAG Spring meeting. We held initial discussions with Novartis regarding Alpelisib for patients with PIK3CA mutations, and participated in developing a project proposal for the EJP RD Joint Transnational Call.

June: VASCAPA attended RaDiOrg’s General Assembly and held its own yearly General Assembly. We presented survey findings on insurance challenges for rare disease patients to the federal Healthcare minister.

August–October: The VASCA Networking event brought together specialists from multiple hospitals. VASCAPA Day 2023 took place on September 9. We participated in VASCERN Days 2023, sharing progress on working groups including patient psychology and pregnancy considerations.

December: The EJP RD project proposal was approved for funding — a significant achievement. Prof. Laurence Boon received the Edelweiss Award recognising her outstanding commitment to patients with vascular anomalies. An extraordinary General Assembly approved statute revisions.

These accomplishments are the result of the voluntary commitment and participation of our members throughout the year. Thank you all!

Similar Posts